Acquired Hemophilia Treatment Market by Product, by Application, by Geography, Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027 - PowerPoint PPT Presentation

} ?>
View by Category
About This Presentation
Title:

Acquired Hemophilia Treatment Market by Product, by Application, by Geography, Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027

Description:

The types of traditional therapies used to treat acquired hemophilia are steroid treatment, cytotoxic therapy, and immunomodulatory therapy. The advanced treatment segmentation includes recombinant activated factor VII/NovoSeven RT, recombinant porcine factor VIII, activated prothrombin complex concentrate (aPCC)/FEIBA, and desmopressin (DDAVP). Bypassing agents such as FEIBA and NovoSeven are used as first-line treatment for controlling bleeding. International recommendations have stated that anti-hemorrhagic treatments should be promptly administered in patients with critical bleeding where acquired hemophilia is confirmed, irrespective of factor VIII activity and inhibitor titer. – PowerPoint PPT presentation

Number of Views:0
Date added: 20 November 2020
Slides: 9
Provided by: uttam217

less

Write a Comment
User Comments (0)
About PowerShow.com